✦ LIBER ✦

361 Preclinical activity of AZD0530, a novel, oral, potent and selective inhibitor of the Src family kinases

✍ Scribed by T.P. Green; M. Fennell; R. Whittaker; J. Curwen; V. Jacobs; J. Allen; P.A. Ple; L.F. Hennequin; G. Costello

Book ID: 118621543
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 145 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80368-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical anticancer activity of the p

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530

✍ Tim P. Green; Mike Fennell; Robin Whittaker; Jon Curwen; Vivien Jacobs; Jack All 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 808 KB

617 POSTER In vivo evaluation of efficac

617 POSTER In vivo evaluation of efficacy and pharmacodynamic biomarkers of AZD0530, a dual-specific Src/Abl kinase inhibitor, in preclinical, subcutaneous xenograft models

✍ A. Logié; V. Jacobs; M. Fennell; J. Hargreaves; R. Westwood; N. Haupt; P. Elvin; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Discovery of Novel 2-(Aminoheteroaryl)-t

Discovery of Novel 2-(Aminoheteroaryl)-thiazole-5-carboxamides as Potent and Orally Active Src-Family Kinase p56Lck Inhibitors.

✍ Ping Chen; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 14 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

Pharmacological profile of AW-814141, a

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

✍ Puneet Chopra; Onkar Kulkarni; Shashank Gupta; Malini Bajpai; Vijay Kanoje; Mani 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Preclinical pharmacokinetics and in vitr

Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL

✍ Amrita V. Kamath; Jian Wang; Francis Y. Lee; Punit H. Marathe 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 341 KB

Identification of a Novel 3,5-Disubstitu

Identification of a Novel 3,5-Disubstituted Pyridine as a Potent, Selective, and Orally Active Inhibitor of Akt1 Kinase.

✍ Sheela A. Thomas; et al. et al. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 9 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.